PL1740163T3 - Wielofazowy preparat antykoncepcyjny na bazie naturalnego estrogenu - Google Patents

Wielofazowy preparat antykoncepcyjny na bazie naturalnego estrogenu

Info

Publication number
PL1740163T3
PL1740163T3 PL05730867T PL05730867T PL1740163T3 PL 1740163 T3 PL1740163 T3 PL 1740163T3 PL 05730867 T PL05730867 T PL 05730867T PL 05730867 T PL05730867 T PL 05730867T PL 1740163 T3 PL1740163 T3 PL 1740163T3
Authority
PL
Poland
Prior art keywords
preparation based
natural estrogen
contraceptive preparation
phase contraceptive
phase
Prior art date
Application number
PL05730867T
Other languages
English (en)
Other versions
PL1740163T5 (pl
Inventor
Jan Endrikat
Bernd Düsterberg
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34979546&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1740163(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of PL1740163T3 publication Critical patent/PL1740163T3/pl
Publication of PL1740163T5 publication Critical patent/PL1740163T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
PL05730867T 2004-04-20 2005-04-15 Wielofazowy preparat antykoncepcyjny na bazie naturalnego estrogenu PL1740163T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004019743A DE102004019743B4 (de) 2004-04-20 2004-04-20 Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
PCT/EP2005/004022 WO2005102247A2 (de) 2004-04-20 2005-04-15 Mehrphasenpräparat zur kontrazeption auf der basis eines natürlichen estrogens
EP05730867.8A EP1740163B2 (de) 2004-04-20 2005-04-15 Mehrphasenpräparat zur kontrazeption auf der basis eines natürlichen estrogens

Publications (2)

Publication Number Publication Date
PL1740163T3 true PL1740163T3 (pl) 2010-12-31
PL1740163T5 PL1740163T5 (pl) 2020-10-05

Family

ID=34979546

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05730867T PL1740163T5 (pl) 2004-04-20 2005-04-15 Wielofazowy preparat antykoncepcyjny na bazie naturalnego estrogenu

Country Status (38)

Country Link
US (3) US8071577B2 (pl)
EP (1) EP1740163B2 (pl)
JP (1) JP4908399B2 (pl)
KR (1) KR20060134168A (pl)
CN (1) CN1946383B (pl)
AR (2) AR048830A1 (pl)
AT (1) ATE473734T1 (pl)
AU (1) AU2005235418C1 (pl)
BR (1) BRPI0510005A (pl)
CA (1) CA2561839C (pl)
CR (1) CR8695A (pl)
CY (1) CY1111292T1 (pl)
DE (2) DE102004019743B4 (pl)
DK (1) DK1740163T4 (pl)
EA (1) EA010313B1 (pl)
EC (1) ECSP067000A (pl)
ES (1) ES2348038T5 (pl)
GT (1) GT200500093A (pl)
HK (1) HK1099701A1 (pl)
HR (1) HRP20100513T4 (pl)
IL (2) IL178510A (pl)
ME (1) ME01183B (pl)
MX (1) MXPA06012213A (pl)
MY (1) MY143669A (pl)
NO (1) NO344098B1 (pl)
NZ (1) NZ550417A (pl)
PA (1) PA8630901A1 (pl)
PE (1) PE20060308A1 (pl)
PL (1) PL1740163T5 (pl)
PT (1) PT1740163E (pl)
RS (1) RS51434B2 (pl)
SI (1) SI1740163T2 (pl)
SV (1) SV2006002090A (pl)
TW (1) TWI351960B (pl)
UA (1) UA83915C2 (pl)
UY (1) UY28863A1 (pl)
WO (1) WO2005102247A2 (pl)
ZA (1) ZA200609594B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
ATE424828T1 (de) * 2005-10-13 2009-03-15 Bayer Schering Pharma Ag Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysfunktionellen uterinen blutung in einheit mit einer oralen kontrazeption
EP1937274B1 (de) * 2005-10-13 2012-02-22 Bayer Pharma Aktiengesellschaft Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysf unktionellen uterinen blutung in einheit mit einer oralen kontrazeption
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
WO2007106264A2 (en) * 2006-03-02 2007-09-20 Warner Chilcott Company, Inc. Extended cycle multiphasic oral contraceptive method
DE102006010329A1 (de) * 2006-03-06 2007-09-13 Höltge, Michael, Dipl.-Med. Hormonelles Kontrazeptivum auf der Basis eines Estrogens, eines Gestagens oder einer Kombination von Estrogenen und Gestagenen unter der Zugabe von Testosteron
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido
US20090117184A1 (en) * 2007-11-05 2009-05-07 Sabine Fricke Use of a gestagen in combination with an estrogen and one or more pharmaceutically acceptable auxiliary agents/excipients for lactose-free oral contraception
AR086395A1 (es) * 2011-05-11 2013-12-11 Kirax Corp Envase para el tratamiento de patologias

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4168068A (en) 1969-07-22 1971-01-28 Unisearch Limited Improvements in or relating to oral contraceptives
US3639600A (en) 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3795734A (en) 1970-04-20 1974-03-05 American Home Prod Cyclic regimen of hormone administration for contraception
US4066757A (en) 1973-03-26 1978-01-03 Ortho Pharmaceutical Corporation Oral contraceptive regimen
DE2365103C3 (de) 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
DE2431704A1 (de) 1974-07-02 1976-01-22 Asche Ag Stufenkombinationspraeparate per kontrazeption
DE2645307A1 (de) 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
JPS6019734B2 (ja) 1977-05-12 1985-05-17 三共株式会社 安定なプロスタグランジンｅ類製剤の製法
US4272270A (en) 1979-04-04 1981-06-09 Petrochem Consultants, Inc. Cryogenic recovery of liquid hydrocarbons from hydrogen-rich
NL8001593A (nl) * 1980-03-18 1981-10-16 Akzo Nv Meerfasisch combinatiepreparaat voor orale anticonceptie.
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4544554A (en) 1983-09-26 1985-10-01 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4530839A (en) 1983-09-26 1985-07-23 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4616006A (en) 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
DE3341638A1 (de) 1983-11-17 1984-05-03 Hermann Dr.rer.nat. 8000 München Heßlinger Dreiphasen-praeparat zur empfaengnisverhuetung aus ethinyloestradiol und lynestrenol
DE3347125A1 (de) 1983-12-22 1985-07-11 Schering AG, 1000 Berlin und 4709 Bergkamen Mehrstufenkombinationspraeparat und seine verwendung zur oralen kontrazeption
AU581486B2 (en) 1985-12-30 1989-02-23 Warner-Lambert Company Graduated estrogen contraceptive
IE61236B1 (en) 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
CA2005933A1 (en) 1989-01-09 1990-07-09 Jesse Hipps, Sr. Photohardenable composition containing five member aromatic group with imine moiety
IE71203B1 (en) * 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
DE4104385C1 (pl) 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich
DE4224534A1 (de) 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
DE4308406C1 (de) 1993-03-12 1994-06-16 Jenapharm Gmbh Kombinationspräparat zur Kontrazeption
DE4313926A1 (de) * 1993-04-28 1994-11-03 Jenapharm Gmbh Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption
DE4339934C2 (de) 1993-05-07 1995-05-24 Klaus Dr Med Umbreit Ovulationshemmendes Mittel zur hormonalen Kontrazeption
NL9301562A (nl) 1993-09-09 1995-04-03 Saturnus Ag Preparaat voor substitutietherapie.
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE4429374C1 (de) 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente
DE19525017A1 (de) 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19540253C2 (de) * 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
US20050032756A1 (en) 1995-10-28 2005-02-10 Michael Dittgen Multistage preparation for contraception based on natural estrogens
DE69724796T2 (de) 1996-07-26 2004-07-01 Wyeth Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
IL127797A (en) 1996-07-26 2004-08-31 Wyeth Corp A one-step method of contraception and a kit containing a combination of progestin and estrogen
CA2261687A1 (en) 1996-07-26 1998-02-05 American Home Products Corporation Oral contraceptive
DE19654609A1 (de) 1996-12-20 1998-06-25 Schering Ag Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder
US6987101B1 (en) 1996-12-20 2006-01-17 Schering Aktiengesellschaft Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
US6312772B1 (en) * 1997-10-20 2001-11-06 Hoechst Celanese Corporation Multilayer laminate formed from a substantially stretched non-molten wholly aromatic liquid crystalline polymer and non-polyester thermoplastic polymer
DE19908762A1 (de) 1999-02-18 2000-08-31 Jenapharm Gmbh Verwendung von Dienogest in hoher Dosierung
DE10045380A1 (de) 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US6699820B2 (en) 2001-03-02 2004-03-02 Hartmut Ulrich Bielefeldt Method for making a superconductor with enhanced current carrying capability
DE10294402D2 (de) 2001-09-29 2004-11-11 Solvay Pharm Gmbh Estrogen-Gestagen Kombinationspräparat und Anwendung
EP1462106A1 (en) 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
US20050032758A1 (en) 2003-06-25 2005-02-10 Ina Rudolph Hormone replacement therapy and depression
DE102004019743B4 (de) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens
BRPI0516247A (pt) 2004-10-07 2008-08-26 Duramed Pharmaceuticals Inc métodos de tratamento hormonal, utilizando regimes de ciclo prolongado de dose crescente
TW200726473A (en) 2005-06-28 2007-07-16 Wyeth Corp Compositions and methods for treatment of cycle-related symptoms
ATE424828T1 (de) 2005-10-13 2009-03-15 Bayer Schering Pharma Ag Verwendung von estradiolvalerat in kombination mit dienogest zur oralen therapie der dysfunktionellen uterinen blutung in einheit mit einer oralen kontrazeption
US8153616B2 (en) 2005-10-17 2012-04-10 Bayer Pharma Aktiengesellschaft Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same
EP1930010A1 (de) 2006-10-20 2008-06-11 Bayer Schering Pharma Aktiengesellschaft Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido

Also Published As

Publication number Publication date
AU2005235418B2 (en) 2009-08-06
GT200500093A (es) 2006-04-17
US20070259840A1 (en) 2007-11-08
RS51434B (en) 2011-04-30
PT1740163E (pt) 2010-09-28
AR048830A1 (es) 2006-05-31
CA2561839C (en) 2009-09-29
HK1099701A1 (en) 2007-08-24
AR084229A2 (es) 2013-05-02
DE102004019743A1 (de) 2005-11-24
CY1111292T1 (el) 2015-08-05
HRP20100513T4 (hr) 2020-10-02
NZ550417A (en) 2010-01-29
US20110124612A1 (en) 2011-05-26
RS51434B2 (sr) 2020-11-30
CN1946383A (zh) 2007-04-11
BRPI0510005A (pt) 2007-09-18
MXPA06012213A (es) 2007-01-17
DE502005009904D1 (de) 2010-08-26
EA200601844A1 (ru) 2007-04-27
EP1740163B2 (de) 2020-01-15
HRP20100513T1 (en) 2010-11-30
DK1740163T3 (da) 2010-10-18
KR20060134168A (ko) 2006-12-27
DE102004019743B4 (de) 2008-11-27
US8071577B2 (en) 2011-12-06
ATE473734T1 (de) 2010-07-15
US20100173877A1 (en) 2010-07-08
EP1740163A2 (de) 2007-01-10
ES2348038T3 (es) 2010-11-29
CR8695A (es) 2008-07-29
ECSP067000A (es) 2006-12-29
ZA200609594B (en) 2008-04-30
JP2007533681A (ja) 2007-11-22
IL239861A0 (en) 2015-08-31
IL178510A (en) 2015-08-31
EP1740163B1 (de) 2010-07-14
CA2561839A1 (en) 2005-11-03
PA8630901A1 (es) 2006-05-16
EA010313B1 (ru) 2008-08-29
MY143669A (en) 2011-06-30
TWI351960B (en) 2011-11-11
SI1740163T2 (sl) 2020-04-30
NO20065292L (no) 2007-01-17
CN1946383B (zh) 2010-06-09
UA83915C2 (ru) 2008-08-26
NO344098B1 (no) 2019-09-02
TW200534860A (en) 2005-11-01
PE20060308A1 (es) 2006-05-25
WO2005102247A2 (de) 2005-11-03
UY28863A1 (es) 2005-11-30
PL1740163T5 (pl) 2020-10-05
DK1740163T4 (da) 2020-04-06
SI1740163T1 (sl) 2010-11-30
JP4908399B2 (ja) 2012-04-04
AU2005235418C1 (en) 2015-05-21
ME01183B (me) 2013-03-20
AU2005235418A1 (en) 2005-11-03
ES2348038T5 (es) 2020-09-14
SV2006002090A (es) 2006-02-15
IL178510A0 (en) 2007-02-11
WO2005102247A3 (de) 2006-01-12

Similar Documents

Publication Publication Date Title
IL239861A0 (en) A multi-phase birth control preparation based on natural estrogen
ZAA200500066S (en) A lavatory device
ZAA200500067S (en) A lavatory device
EP1711708A4 (en) HYDROELECTRIC POWER PLANT
AU300001S (en) A bag
GB0427922D0 (en) A refuelling aid
EP1788911A4 (en) OPERATING A THREE-PHASE DEVICE WITH ONE-PHASE CURRENT
HK1078413A2 (en) A brassiere
GB2410745B (en) Cholestanyl derivatives
GB0318033D0 (en) A turbine
GB0328266D0 (en) A turbine
GB2406790B (en) A herbal analgesic preparation
GB0402769D0 (en) A mixer
AU156813S (en) A letterbox
AU152562S (en) A trip lever
AU305420S (en) A spout
GB0412732D0 (en) A kettle
PL370545A1 (pl) Lotnia
AU302076S (en) A sanitary fitting
AU300751S (en) A sanitary fitting
GB0422214D0 (en) Chair for a couple
IL165321A0 (en) 9-alpha-substituted estratrienes as selectively active estrogen
ZAA200500065S (en) A lavatory device
ZAA200500063S (en) A lavatory device
ZAA200500064S (en) A lavatory device